德尔塔
您当前所在位置:首页 > 宣传资料 > 材料科学 > 材料科学

「同位素标记抑制剂」Bosutinib-d8

发布时间:2025-06-10     作者:德尔塔生物   分享到:

【产品介绍】:

生物活性:Bosutinib-d8 is a deuterium labeled Bosutinib. Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively[1][2].
IC50 & Target:IC50: 1.2 nM (Src), 1 nM (Abl)[1]
分子量:538.50
Formula:C26H21D8Cl2N5O3
非标记 CAS:380843-75-4
性状:固体
颜色:White to off-white
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years,4°C:2 years
In solvent:-80°C:6 months,-20°C:1 month
纯度 & 产品资料
纯度: ≥99.0%
参考文献
[1]. Boschelli DH, et al. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem, 2001, 44(23), 3965-3977.
 [Content Brief]
[2]. Golas JM, et al. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice. Cancer Res, 2003, 63(2), 375-381.
 [Content Brief]